Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Cellular and Molecular Biology Letters

More options …
Volume 12, Issue 3

Issues

The effect of TGF-β1 and Smad7 gene transfer on the phenotypic changes of rat alveolar epithelial cells

Guo-Ping Xu / Qing-Quan Li / Xi-Xi Cao / Qi Chen / Zhong-Hua Zhao / Zi-Qiang Diao / Zu-De Xu
Published Online: 2007-04-25 | DOI: https://doi.org/10.2478/s11658-007-0018-x

Abstract

The aim of this study was to investigate whether transforming growth factor-β1 (TGF-β1) could induce alveolar epithelial-mesenchymal transition (EMT) in vitro, and whether Smad7 gene transfer could block this transition. We also aimed to elucidate the possible mechanisms of these processes. The Smad7 gene was transfected to the rat type II alveolar epithelial cell line (RLE-6TN). Expression of the EMT-associated markers was assayed by Western Blot and Real-time PCR. Morphological alterations were examined via phase-contrast microscope and fluorescence microscope, while ultrastructural changes were examined via electron microscope. TGF-β1 treatment induced a fibrotic phenotype of RLE-6TN with increased expression of fibronectin (FN), α-smooth muscle actin (α-SMA) and vimentin, and decreased expression of E-cadherin (E-cad) and cytokeratin19 (CK19). After transfecting the RLE-6TN with the Smad7 gene, the expression of the mesenchymal markers was downregulated while that of the epithelial markers was upregulated. TGF-β1 treatment for 48 h resulted in the separation of RLE-6TN from one another and a change into elongated, myofibroblast-like cells. After the RLE-6TN had been transfected with the Smad7 gene, TGF-β1 treatment had no effect on the morphology of the RLE-6TN. TGF-β1 treatment for 48 h resulted in an abundant expression of α-SMA in the RLE-6TN. If the RLE-6TN were transfected with the Smad7 gene, TGF-β1 treatment for 48 h could only induce a low level of α-SMA expression. Furthermore, TGF-β1 treatment for 12 h resulted in the degeneration and swelling of the osmiophilic multilamellar bodies, which were the markers of type II alveolar epithelial cells. TGF-β1 can induce alveolar epithelialmesenchymal transition in vitro, which is dependent on the Smads signaling pathway to a certain extent. Overexpression of the Smad7 gene can partially block this process

Keywords: Epithelial-mesenchymal transition; Gene transfer; Smad7; Transforming growth factor-β1

  • [1] Selman, M., King, T.E. and Pardo, A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134 (2001) 136–151. Google Scholar

  • [2] King, T.E., Schwarz, M.I., Brown, K., Tooze, J.A., Colby, T.V., Waldron, J.A., Flint, A., Thurlbeck, W. and Cherniack, R.M. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am. J. Respir. Crit. Care Med. 164 (2001) 1025–1032. Google Scholar

  • [3] Selman, M. and Pardo, A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res. 3 (2002) 3. http://dx.doi.org/10.1186/rr175CrossrefGoogle Scholar

  • [4] Yao, H.W., Xie, Q.M., Chen, J.Q., Deng, Y.M. and Tang, H.F. TGF-beta 1 induces alveolar epithelial to mesenchymal cell transition in vitro. Life Sci. 76 (2004) 29–37. http://dx.doi.org/10.1016/j.lfs.2004.06.019Web of ScienceGoogle Scholar

  • [5] Gauldie, J., Kolb, M. and Sime, P.J. A new direction in the pathogenesis of idiopathic pulmonary fibrosis? Respir Res. 3 (2002) 1. http://dx.doi.org/10.1186/rr158CrossrefGoogle Scholar

  • [6] Kalluri, R. and Neilson, E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112 (2003) 1776–1784. http://dx.doi.org/10.1172/JCI200320530CrossrefGoogle Scholar

  • [7] Liu, Y. Epithelial to mesenchymal transition in renal fibrogenesis: athologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15 (2004) 1–12. http://dx.doi.org/10.1097/01.ASN.0000106015.29070.E7CrossrefGoogle Scholar

  • [8] Desmouliere, A., Darby, I.A. and Gabbiani, G. Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab. Invest. 83 (2003) 1689–1707. http://dx.doi.org/10.1097/01.LAB.0000101911.53973.90CrossrefGoogle Scholar

  • [9] Moustakas, A., Pardali, K. and Gaal, A. Mechanisms of TGF-b signaling in regulation of cell growth and differentiation. Immunol. Lett. 82 (2002) 85–91. http://dx.doi.org/10.1016/S0165-2478(02)00023-8CrossrefGoogle Scholar

  • [10] Desmouliere, A. Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol. Int. 19 (1995) 471–476. http://dx.doi.org/10.1006/cbir.1995.1090CrossrefGoogle Scholar

  • [11] ten Dijke, P., Goumans, M.J., Itoh, F. and Itoh, S. Regulation of cell proliferation by Smad proteins. J. Cell Physiol. 191 (2002) 1–16. http://dx.doi.org/10.1002/jcp.10066CrossrefGoogle Scholar

  • [12] Massague, J. and Wotton, D. Transcriptional control by the TGF-b/Smad signaling system. EMBO J. 19 (2000) 1745–1754. http://dx.doi.org/10.1093/emboj/19.8.1745CrossrefGoogle Scholar

  • [13] Derynck, R. and Zhang, Y.E. Smad-dependent and Smad-independent pathways in TGF-b family signaling. Nature 425 (2003) 577–584. http://dx.doi.org/10.1038/nature02006CrossrefGoogle Scholar

  • [14] Lan, H.Y., Mu, W., Tomita, N., Huang, X.R., Li, J.H. and Zhu, H.J. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using Ultrasound-microbubble system in rat UUO model. J. Am. Soc. Nephrol. 14 (2003) 1535–1548. http://dx.doi.org/10.1097/01.ASN.0000067632.04658.B8CrossrefGoogle Scholar

  • [15] Dooley, S., Hamzavi, J., Breitkopf, K., Wiercinska, E., Said, H.M., Lorenzen, J., ten Dijke, P. and Gressner, A.M. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125 (2003) 178–191. http://dx.doi.org/10.1016/S0016-5085(03)00666-8CrossrefGoogle Scholar

  • [16] Zavadil, J. and Bottinger, E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24 (2005) 5764–5774. http://dx.doi.org/10.1038/sj.onc.1208927CrossrefGoogle Scholar

  • [17] Greenburg, G. and Hay, E.D. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J. Cell Biol. 95 (1982) 333–339. http://dx.doi.org/10.1083/jcb.95.1.333CrossrefGoogle Scholar

  • [18] Stoker, M. and Perryman, M. An epithelial scatter factor released by embryo fibroblasts. J. Cell Sci. 77 (1985) 209–23. Google Scholar

  • [19] Miettinen, P.J., Ebner, R., Lopez, A.R. and Derynck, R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 127 (1994) 2021–2036. http://dx.doi.org/10.1083/jcb.127.6.2021CrossrefGoogle Scholar

  • [20] Kalluri, R. and Neilson, E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112 (2003) 1776–1784. http://dx.doi.org/10.1172/JCI200320530CrossrefGoogle Scholar

  • [21] Saika, S., Kono-Saika, S., Tanaka, T., Yamanaka, O., Ohnishi, Y., Sato, M., Muragaki, Y., Ooshima, A., Yoo, J., Flanders, K.C. and Roberts, A.B. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab. Invest. 84 (2004) 1245–1258. http://dx.doi.org/10.1038/labinvest.3700156CrossrefGoogle Scholar

  • [22] Valcourt, U., Kowanetz, M., Niimi, H., Valcourt U., Heldin, C.H. and Moustakas, A. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell. 16 (2005) 1987–2002. http://dx.doi.org/10.1091/mbc.E04-08-0658CrossrefGoogle Scholar

  • [23] Lan, H.Y., Mu, W., Tomita, N., Huang, X.R., Li, J.H., Zhu, H.J., Morishita, R. and Johnson, R.J. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J. Am. Soc. Nephrol. 14 (2003) 1535–1548. http://dx.doi.org/10.1097/01.ASN.0000067632.04658.B8CrossrefGoogle Scholar

About the article

Published Online: 2007-04-25

Published in Print: 2007-09-01


Citation Information: Cellular and Molecular Biology Letters, Volume 12, Issue 3, Pages 457–472, ISSN (Online) 1689-1392, DOI: https://doi.org/10.2478/s11658-007-0018-x.

Export Citation

© 2007 University of Wrocław, Poland. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Dongyun Huang, Wenjing Xu, Xingxiang Xu, Xudong Zhang, Rui Zhou, and Ping Chen
Oncology Letters, 2016, Volume 12, Number 6, Page 5052
[2]
Paolo Comeglio, Annamaria Morelli, Luciano Adorini, Mario Maggi, and Linda Vignozzi
Expert Opinion on Investigational Drugs, 2017, Volume 26, Number 11, Page 1215
[3]
Paolo Comeglio, Sandra Filippi, Erica Sarchielli, Annamaria Morelli, Ilaria Cellai, Francesca Corcetto, Chiara Corno, Elena Maneschi, Alessandro Pini, Luciano Adorini, Gabriella Barbara Vannelli, Mario Maggi, and Linda Vignozzi
The Journal of Steroid Biochemistry and Molecular Biology, 2017, Volume 168, Page 26
[4]
Mikihisa Takano, Chieko Yamamoto, Koki Yamaguchi, Masashi Kawami, and Ryoko Yumoto
Drug Metabolism and Pharmacokinetics, 2015, Volume 30, Number 1, Page 111
[5]
Qiao-dan Zhou, Yong Ning, Rui Zeng, Lin Chen, Pei Kou, Chu-ou Xu, Guang-chang Pei, Min Han, and Gang Xu
Journal of Huazhong University of Science and Technology [Medical Sciences], 2013, Volume 33, Number 5, Page 672
[6]
Jian Xu, Samy Lamouille, and Rik Derynck
Cell Research, 2009, Volume 19, Number 2, Page 156

Comments (0)

Please log in or register to comment.
Log in